Zentalis Pharmaceuticals, Inc. (ZNTL) › Operating Cash FlowZentalis Pharmaceuticals, Inc. (ZNTL) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2019: -$39.14M2020: -$86.83M2021: -$154.09M2022: -$163.75M2023: -$207.82M2024: -$170.86M2025: -$125.25M-$125.25M2019Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$125.25M+26.7%2024-$170.86M+17.8%2023-$207.82M-26.9%2022-$163.75M-6.3%2021-$154.09M-77.5%2020-$86.83M-121.8%2019-$39.14M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share